ORL Department, Menoufia University Hospital, Shibin Elkom, Egypt.
Eur Arch Otorhinolaryngol. 2012 Feb;269(2):537-44. doi: 10.1007/s00405-011-1715-7. Epub 2011 Aug 4.
Several promising candidate drugs that target bacterial adherence and biofilm formation are being developed. Such hopeful drugs cannot be studied in chronic rhinosinusitis (CRS) without the evaluation of such virulence criteria in different forms of the disease with and without nasal polyposis (CRSwNP and CRSsNP). The aim of this study was to evaluate bacterial adherence, response to antibiotics and degree of accumulation of bacterial biofilms as new targets of treatment in CRSwNP and CRSsNP. Twenty CRS patients and 10 normal subjects with airway obstructing concha bullosa were prospectively enrolled in the present study. Scanning electron microscopy and cultures were performed on paranasal sinus tissue samples. Bacterial adherence tests using the tissue culture plate method were measured quantitatively. Strongly adherent bacteria were identified significantly in 6/9 (77%) cases of CRSsNP in comparison to 1/7 (14%) cases of CRSwNP. Strongly adherent bacteria that were sensitive to ciprofloxacin, vancomycin, and impenim were identified in 75% of the cultured coagulase positive staphylococci. A significant difference (P = 0.007) in the degree of accumulation of bacterial biofilms existed between the two groups. In CRSsNP, a more advanced stage of bacterial biofilms with strong bacterial adherence was observed which make them attractive targets for new drugs. In CRSwNP, lower stage bacterial biofilms with low bacterial adhesion were identified, which may help explain the low bacterial virulence in an environment of suboptimal, organizational arrangements.
有几种有前途的靶向细菌黏附和生物膜形成的候选药物正在开发中。如果不在伴有和不伴有鼻息肉(CRSwNP 和 CRSsNP)的不同形式的疾病中评估这些毒力标准,就不能在慢性鼻-鼻窦炎(CRS)中研究这些有希望的药物。本研究旨在评估细菌黏附、对抗生素的反应和细菌生物膜积累程度,作为 CRSwNP 和 CRSsNP 的新治疗靶点。本研究前瞻性纳入了 20 例 CRS 患者和 10 例伴有气道阻塞性鼻甲肥大的正常受试者。对鼻窦组织样本进行扫描电子显微镜检查和培养。采用组织培养板法进行细菌黏附试验,定量测量。与 CRSwNP 相比,CRSsNP 中 6/9(77%)例存在强黏附菌,而 CRSwNP 中仅 1/7(14%)例存在强黏附菌。在培养的凝固酶阳性葡萄球菌中,75%的强黏附菌对环丙沙星、万古霉素和IMPENIM 敏感。两组之间细菌生物膜积累程度存在显著差异(P=0.007)。在 CRSsNP 中,观察到更高级阶段的细菌生物膜,具有较强的细菌黏附性,这使其成为新药物的有吸引力的靶点。在 CRSwNP 中,识别到低阶段细菌生物膜,其细菌黏附性较低,这可能有助于解释在组织排列不佳的环境中细菌毒力较低的原因。